Cochrane Corner: Intra-aortic balloon pump in patients with cardiogenic shock following myocardial infarction

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Improvement of hemodynamic parameters is the rationale for the use of intra-aortic balloon pump counterpulsation (IABP) in patients with cardiogenic shock following acute myocardial infarction (MI). This Cochrane systematic review evaluated the impact of this intervention in reducing mortality. Seven randomized controlled trials with a total of 790 patients were included (four using medical therapy as a comparator, and three comparing IABP with other ventricular assist devices). IABP did not reduce mortality in either the short or long term. Therefore, the systematic use of IABP in patients with cardiogenic shock following MI cannot be recommended.

Cite

CITATION STYLE

APA

Caldeira, D., Pereira, H., Costa, J., & Vaz-Carneiro, A. (2016). Cochrane Corner: Intra-aortic balloon pump in patients with cardiogenic shock following myocardial infarction. Revista Portuguesa de Cardiologia, 35(4), 229–231. https://doi.org/10.1016/j.repc.2015.09.013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free